Publisher
Springer Science and Business Media LLC
Subject
Hematology,Histology,Pathology and Forensic Medicine
Reference11 articles.
1. Saygin C, Kishtagari A, Cassaday RD, Reizine N, Yurkiewicz I, Liedtke M et al (2019) Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes. Blood Adv 3:4228–4237
2. Whittle SB, Punia JN, López-Terrada D, Gaikwad A, Hampton OA, Heczey A (2017) Therapy-related acute leukemia with mixed phenotype and Novel t(1: 6)(q25;p23) after treatment for high-risk neuroblastoma. J Pediatr Hematol Oncol 39(8):e486–e488
3. Yang D, Cho SR, Jung S, Lee W, Hwang HY, Lee HS et al (2017) A case of therapy-related acute leukemia with mixed phenotype with BCR-ABL1 after treatment of diffuse large B-cell lymphoma. Ann Lab Med 37:166–168
4. Gong X, Yan L, Xiao X, Tang Q, Zhao X (2018) Secondary mixed phenotype acute leukemia following chemotherapy for diffuse large B-cell lymphoma: a case report and review of the literature. Int J Clin Exp Pathol 11:3104–3110
5. Yamamoto K, Sada A, Kawano Y, Katayama Y, Shimoyama M, Matsui T (2010) Therapy-related, mixed phenotype acute leukemia with t(1;21)(p36;q22) and RUNX1 rearrangement. Cancer Genet Cytogenet 201:122–127